Tag Archives: Pandemic

Rakshabandhan in 2020: How it is going to be different…

“There’s no other love like the love for a brother. There’s no other love like the love from a brother.” –Astrid Alauda

Rakshabandhan is popular, traditionally Hindu, annual rite, or ceremony, which is central to a festival of the same name, celebrated in India, Nepal, and other parts of the Indian subcontinent, and among people around the world influenced by Hindu culture. The festival is a festival of love, care, and happiness. It symbolizes the existing love between brother and sister. On this day, sisters of all ages tie a talisman, or amulet, called the rakhi, around the wrists of their brothers, symbolically protecting them, receiving a gift in return, and traditionally investing the brothers with a share of the responsibility of their potential care.

Despite being a part of Hindu culture, due to its moral values, the festival is celebrated by other cultures as well. Among women and men who are not blood relatives, there is also a transformed tradition of voluntary kin relations, achieved through the tying of rakhi amulets, which have cut across caste and class lines, and Hindu and Muslim divisions. In some communities or contexts, other figures, such as a matriarch, or a person in authority, can be included in the ceremony in ritual acknowledgment of their benefaction.

Every year, this festival has been awaited by all of us. It gives a chance for the celebration of a selfless and beautiful relation. For some families, this is the occasion where sisters get a chance (out of their busy schedule) to finally visit their brother and celebrate their love. The occasion begins from the previous day itself, with sisters buying beautiful rakhis and sweets for their brothers and applying Mehendi on their hands. Next early morning, both sisters and brothers dress up in new clothes. The sister ties Rakhi on brother’s hand offers him sweet and sings love songs for him depicting brother-sister relation. The brother then gives her sister a gift and along with that a promise of “protection against any problem in her life.”

Every year, this is the time when families travel to each others’ houses to celebrate the festival. But this time, the festival falls amid these harsh times when the whole world is standing against a pandemic, COVID-19. Rakshabandhan is the first major festival of Hindus after the beginning of the pandemic. Therefore, it is a challenge for all of us to get along with the charm of the festival by taking all the precautions and by maintaining social distancing. This year, it is difficult for sisters to visit their brothers if they live in a different city or state. Each year, we can easily have a get-together and celebrate the festival. But, every year, we have our soldiers, policemen, doctors, workers who are away from their home, on their duty even during festivals for the service of their country. This time, we have got a very golden chance to serve our country and fight against the pandemic by staying at our homes. We can spread happiness and celebrate the festival with our police brothers, doctors, and nurses who are truly working as our safeguard for our protection. We can tie Rakhi out of respect to them, making them realize that they are true heroes and fulfilling the responsibilities of a brother. 

Apart from this, in this time of the internet, even though we are staying far, we are always connected through the internet. We are never apart. We can celebrate the festival over a video call. It will a new experience and it will be great fun. One more thing we need to remember that though some sisters are not able to go to their brother, due to pandemic, colleges and schools are closed. This brings young brothers and sisters together who usually don’t get holidays on Rakshabandhan when colleges run regularly. They must be together after a long time and enjoying the togetherness.

“As we grew up, my brothers acted like they didn’t care, but I always knew they looked out for me and were there!” – Catherine Pulsifer

DOES PANDEMIC PUSH INTO DRASTIC POVERTY?


India has already crossed 700,000 marks in positive COVID19 cases. Its spread does not seem to be declining; infections and death toll continue to surge frighteningly instead. The whole world is under home arrest for months to deal with this epidemic. The pandemic-induced lockdown kept a huge part of economy trailing which even though couldn’t demolish the middle or upper class as much as it derailed the lower class off the tracks. Even if ignored, half of India’s population is built with the most ignored class of society. A spot on this population can indeed pull down the economy.
At first, let’s take a look at,
What could be the impact on the economy?
• The rise in unemployment.
• The collapse of small trades like street shops.
• A slump in the tourism industry.
• The decline of the hospitality industry
• Sudden fall down of government resources.
• Rising prices making unaffordable food.
• It makes the situation even worse for poor Countries.
Keeping these points in mind, questions prevail as to the demands and need of the lower class. Most of the points mentioned above hamper this class directly; which is highly dependent on government-provided services and not on private sectors.
Labours who migrate elsewhere in the hope of better living are returning empty-handed, which on the surface has both dark and fair sides which are up to debate. However, a potential fact is always lost which takes concern upon the lives of these workers.
“16 migrant workers were crushed to death by the wheels of the train in Aurangabad station while they were resting.”
Street vendors are counting days in the hope that all will be sorted someday. Jobs like these which pay itself just to have square a meal each day with altogether zero savings whatsoever is clearly under attack.
Basic multipurpose factories and industries had to pull their shutters down under the strict notice of lockdown.
All these factors, considered, is leaving the middle and lower class with lower and lowest money in hand respectively. The direct conflict rises when the lower financial flow in the houses is stretching market flow into narrow wires, which only the upper-middle and upper class are keeping existent.
The Indian economy has fallen drastically. The poor people; though they are an integral part of our economy are going through an extremely pathetic condition.
WHO (World Health Organization) already announced that living with COVID19 is a new normal now.
Though the Government came forward to help the miserable people with some grants it cannot run indefinitely. The pandemic is temporary. This disruptive condition will be resolved one day. So, it is needless to say that our economy will recover quickly and hopefully the government will handle the disaster with proper efficiency. All states should make a head start to fight against the epidemic. The government might get the second wind which will save the country from the disaster.

China’s bio weapon

In December 2019 during the time of Christmas in the virology institute of China, Wuhan leaked a virus. After few days some people were admitted in the hospital due to cough and headache the doctors treated them and let go. Next day some people were admitted in the hospital due to the same symptom then the doctors treated them and let go of them. The next day so many people were admitted in the hospital due to same symptom then the doctors asked them for blood test. In the blood test had understood that people are infected with corona virus.After few days some people were found dead when the test results came they also had Novel corona virus. Then doctors understood the seriousness about this virus.They started to find the first admited patients due to this they found them and asked where did you went before coming to hospital they said they went to Live anolimal market of Wuhan. They found all of the people who went to the market there were so many people and they isolated them and asked who all did you meet .They met so many people so they understood that the count of the numbers of the patients wil be very huge. In the same day itself somany people died. This was the first outbreak covid 19 virus and now the virus has spread all over world.

COVAXIN

What is Covaxin?

It has been developed by the company Bharat Biotech India (BBIL) in collaboration with ICMR’s National Institute of Virology (NIV). It is an “inactivated” vaccine — one made by using particles of the Covid-19 virus that were killed, making them unable to infect or replicate. Injecting particular doses of these particles serves to build immunity by helping the body create antibodies against the dead virus, according to BBIL.

News about Covaxin

Earlier this week, Bharat Biotech announced that it had developed a vaccine against the novel coronavirus, named Covaxin, together with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune. The company had also received permission from the Drug Controller General of India (DCGI) to begin human trials, expected to commence in August.

Bharat Biotech is a reputed drug manufacturer that delivers four billion doses around the world for infections like rotavirus, hepatitis, Zika, Japanese encephalitis and others. However, its claim that Covaxin is indigenous – advanced, among others, by managing director Krishna Ella – raises some doubts.

According to Bharat Biotech, Covaxin is an inactivated vaccine developed from an Indian strain of the novel coronavirus isolated by NIV. No further information has been provided, especially about the nature of the vaccine or how it was developed. There have been no prior announcements either about when the process of developing such a vaccine was begun.

ICMR transferred the strain NIV had isolated to Biotech Bharat on May 9. The company published its press release on June 29. So there were only 50 days in between, during which time the company should have developed the inactivated vaccine, conducted preclinical animal trials (with mice and hamsters, according to the company), and sent its reports to be evaluated and approved by DCGI. Although ICMR had promised to expedite the process, animal trials with mice typically take at least three months to conclude.

A related issue is that animal trials for COVID-19 can only be conducted with hACE2 transgenic mice, as ‘normal’ mice can’t get infected with the novel coronavirus. These mice need to be shipped from the US, Europe or China.

These issues therefore raise concerns about whether Bharat Biotech could really have proceeded to the human-trials phase of vaccine development within only 50 days of receiving the inactivated virus from NIV.

Collaboration with US company

Bharat Biotech has currently invested in two other vaccines: CoroFlu in collaboration with FluGen Inc. and the University of Wisconsin-Madison, and an inactivated rabies vaccine vehicle for coronavirus proteins developed along with Matthis Schnell, director of the Jefferson Vaccine Centre (JVC), Pennsylvania. The latter is of interest.

On May 20, Bharat Biotech announced its collaboration with JVC as well as the license it had received to conduct clinical trials, and to produce and deliver vaccines in 80 countries excluding the US, Europe and Japan. On April 7, JVC announced a promising vaccine candidate named Coravax.

Coravax uses an inactivated rabies vaccine to carry the spike protein of the novel coronavirus. The spike protein attaches to a host cell and causes an infection, so experts expected this vaccine to trigger a good immune response on the body’s part. Schnell corroborated this response following preliminary tests with animals. Schnell added that JVC would need one more month to complete follow-up studies.

Bharat Biotech hasn’t shared any technical details of Covaxin. But based on what we already know, there appears to be room for the possibility that Covaxin is Coravax by another name – and by another viral strain. And even if the vaccine is wholly indigenous, the timelines for the animal trials don’t line up.

When does ICMR plan to launch it?

Aiming to make it available for public use by August 15, Bhargava wrote to the 12 trial sites to ensure “all” clinical trials were conducted by then. While BBIL’s application with the Clinical Trials Registry of India (CTRI) shows it plans to complete enrolment of trial participants by July 13, Bhargava has directed the sites to complete enrolment by July 7.

Is this even achievable?

A vaccine usually goes through three phases of human trials. The Central Drugs Standard Control Organization has given approvals for phase I and II trials so far. According to details from CTRI, BBIL in its application estimated phase I and II trials to take a year and three months, including at least a month for phase I alone.

Experts have questioned how all three phases can be concluded within a month and a half. “I would find it very surprising if it is done. Even the most ambitious companies in the world that are in more advanced stages of development for their Covid-19 vaccines have a longer time-frame. Even having all the trial results, with safety and efficacy data, by August 15 is difficult. This raises several questions,” said Dr Anant Bhan, Researcher, Global Health, Bioethics and Health Policy.

While vaccine trials can be fast-tracked, it still takes over a year to launch the product, experts said. In a pandemic, emergency-use approval can be given if data from the first two trial phases is compelling enough, said an expert on condition of anonymity. This would allow the launch without the third phase being conducted, but this approval would likely be given with riders to submit additional data and adverse event reports.

Happy National Doctor’s Day

Every year on 1st July India celebrates National Doctor’s Day in honor of Bharat Ratna Dr. Bidhan Chandra Roy former chief minister of West Bengal and someone who represented the best of his profession at a critical time in India’s modern history.

He is still considered the greatest Chief Minister of West Bengal and a visionary of developing the State as after independence lot of industrial development took place in the State.
He was the one to establish the Indian Medical Association in 1928 and the Medical Council of India. He also played a crucial role in establishing the Indian Institute of Mental Health, the Infectious Disease Hospital, and even Kolkata’s first-ever postgraduate medical college.

My Tribute to our life Saviors

And on this Doctor’s Day salute to all the doctors and healthcare workers for their selfless service. In this pandemic, they are real-life heroes, bringing hope in these difficult situations. Keeping us safe, fighting the coronavirus war at The frontline. Their invaluable contribution makes people recover from this dreadful disease.

Free food grain scheme extension till November : PM Modi

PM Modi addressing Nation

Keeping the pandemic in mind Prime Minister Narendra Modi on Tuesday announced the extension of a key government scheme for free food grain to more than 80 crore poor people till November.

PM Modi’s announcement came during his address to the nation as the country’s coronavirus disease (Covid-19) tally surged beyond 5.66 lakh.

“This time of festivals also increases needs and expenses. Keeping all these things in mind, it has been decided that the Pradhan Mantri Garib Kalyan Anna Yojana should now be extended till Diwali and Chhath Puja, that is, by the end of November,” PM Modi said in his sixth address to the nation since the coronavirus pandemic started.

“More than Rs 90,000 crore will be spent in this expansion of Pradhan Mantri Garib Kalyan Ann Yojna. If you add the expenses of the last three months to it, then it becomes almost one and a half lakh crore rupees,” he added during the virtual address.

PM Modi said that “hardworking farmers and honest taxpayers” have helped push the government’s food scheme as he thanked them for their efforts.

“Today, if the government is able to provide free food grains to the poor and the needy, the credit goes to two sections. First, the hardworking farmers of our country and second, the honest taxpayers. I thank you from my heart,” he said.

PM Modi also urges people of the country to continue to follow the rules of WHO, wearing masks, washing hands, and maintaining the distance of two-yard. He also stressed not to be careless about these rules.

“With this resolve, we 130 crore countrymen have to work together with the resolution to work and move forward. Once again I pray for you and urge all of you to be healthy, keep following the two-yard rule, use gamchas, and mask always. Do not be careless,” he said.

“Earlier, we were very cautious about masks, maintaining a two-yard distance, washing hands several times a day for 20 seconds,” the Prime Minister said.

He also appreciated that the ruled were followed by the government, local body entities, and citizens of the country.

“The rules were followed very seriously during the lockdown. Now governments, local body entities, citizens of the country need to show the same vigilance again,” he added.

India reported 18,522 new Covid-19 cases in the last 24 hours, slightly lower than Sunday’s record of 19,906, according to the Union health ministry Tuesday.

India is behind only the United States, Brazil, and Russia in total cases with more than 566,000 infections. More than 16,800 people have died in the country.

CORONAVIRUS VACCINE DEVELOPMENTS

What is coronavirus?

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.  Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.

The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. The COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette.

At this time, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments. So sooner or later, we are going to come up with a permanent solution for this virus too.

Vaccine developments

With confirmed COVID-19 cases worldwide surpassing 9 million and continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease’s damage. Some of the earliest treatments will likely be drugs that are already approved for other conditions, or have been tested on other viruses.

As of May 8, two medications had received emergency use authorization (EUA) from the Food and Drug Administration (FDA): the antiviral remdesivir and a drug used to sedate people on a ventilator.

The FDA issued a EUA in March for the antimalaria drugs chloroquine and hydroxychloroquine, but later revoked it after studies showed that they’re unlikely to be effective in treating COVID-19.

EUA allows doctors to use these drugs to treat people with COVID-19 even before the medications have gone through the formal FDA approval process. These drugs are still being tested in clinical trials to see whether they’re effective against COVID-19. This step is needed to make sure the medications are safe for this particular use and what the proper dosage should be.

It could be months before treatments are available that are known to work against COVID-19. It could be even longer for a vaccine. But there are still other tools we can use to reduce the damage done by the new coronavirus, also known as SARS-CoV-2.

Antivirals

Remdesivir: Developed a decade ago, this drug failed in clinical trials against Ebola in 2014. But it was found to be generally safe in people. Research with MERS, a disease caused by a different coronavirus, showed that the drug blocked the virus from replicating. The drug is being tested in many COVID-19 clinical trials around the world. This includes studies in which remdesivir is being administered alongside other drugs, such as the anti-inflammatory drug baricitinib. The drug is also being tested in children with moderate to severe COVID-19. In late April, the drug’s manufacturer, Gilead Sciences, announced one of its trials had been “terminated” due to low enrollment. Gilead officials said the results of that trial had been “inconclusive” when it was ended.

A few days later, the company announced that preliminary data from another trial of remdesivir overseen by the National Institute of Allergy and Infectious Diseases (NIAID) had “met its primary endpoint.” Gary Schwitzer, founder of HealthNewsReview.org, though, said the researchers changed the primary endpoint 2 weeks before Fauci’s announcement. Schwitzer compared that to moving football goalposts closer to make it easier to get a touchdown. At the same time, another study published in The Lancet reported that participants in a clinical trial who took remdesivir showed no benefits compared to people who took a placebo.

Despite the conflicting results, the FDA issued an order on May 1 for the emergency use of remdesivir. In early June, federal officials announced their supply of remdesivir will run out by the end of June. Gilead is ramping up production, but it’s unclear how much of the drug will be available this summer.

Arbidol: This antiviral was tested along with the drug lopinavir/ritonavir as a treatment for COVID-19. Researchers reported in mid-April that the two drugs didn’t improve the clinical outcomes for people hospitalized with mild to moderate cases of COVID-19.

EIDD-2801: This drug was created by scientists at a nonprofit biotech company owned by Emory University. Research in mice has shown that it can reduce replication of multiple coronaviruses, including SARS-CoV-2.

Pharmaceutical company Merck and Ridgeback Biotherapeutics LP signed an agreement in May to develop this drug. It’s already being tested in a clinical trial in the United Kingdom. Unlike remdesivir, EIDD-2801 can be taken orally, which would make it available to a larger number of people.

Favipiravir: This drug is approved in some countries outside the United States to treat influenza. Some reports from China suggest it may work as a treatment for COVID-19. These results, though, haven’t been published yet. Japan, where the medication is made, is sending the drug to 43 countries for clinical trial testing in people with mild or moderate COVID-19. Canadian researchers are testing to see whether the drug can help fight outbreaks in long-term care homes.

Kaletra: This is a combination of two drugs — lopinavir and ritonavir — that work against HIV. Clinical trials are being done to see whether it also works against SARS-CoV-2. One small study published May 4 in the journal Med by Cell Press found that lopinavir/ritonavir didn’t improve outcomes in people with mild or moderate COVID-19 compared to those receiving standard care.

Another study, published May 7 in the New England Journal of Medicine, found that the drug combination wasn’t effective for people with severe COVID-19. But another study found that people who were given lopinavir/ritonavir along with two other drugs — ribavirin and interferon beta-1b — took less time to clear the virus from their body. This study was published May 8 in The Lancet.

Merimepodib (VX-497): This drug developed by ViralClear Pharmaceuticals Inc. has been shown previously to have antiviral and immune-suppressing effects. It was tested against hepatitis C but had only modest effects.

The company is running a phase II trial of this drug. People with advanced COVID-19 will be randomized to receive either merimepodib with remdesivir, or remdesivir plus a placebo. The company hopes to have results by late summer of this year.

Current status of the animals in COVID-19 pandemic

Have you ever wondered while you’re at home safely; the doctors, nurses, police, army are the real warriors fighting in this pandemic. But what about the animals around us and in the wildlife sanctuaries? The pets may be safe, but the lone strangers are in need, and we need to help them. In this situation, the activities of poachers have been increasing a lot and can be a significant threat to wild animals, including the endangered animals.

Let’s start with something positive first. One of the facts that researchers were in shock after noticing the penguins are so happy after enjoying with less sea ice; it made them roam and dive freely in the water. Also, the bees, due to less pollution, are now able to find flowers easily. You may also see news like the animals in the zoo are roaming freely; nature is recovering, and much more. But that isn’t the reality. There’s a dark secret hidden behind these hysterical scenes.

A happy penguin looking at you while reading this article

People being unemployed in rural areas prone to move towards illegal activities. In Kenya, also Cambodia and some parts of Africa where bushmeat is increasing a lot. The rhinos are in danger for their horn, although there is no possible way to supply them due to restrictions. The protection in those areas might have reduced due to severe health complications in the countries, so they get an easy escape and a great start planning to earn money. The current situations have worsened day by day as the patients are increasing, beds are reducing, and the government is more focused on healthcare systems.

The technology wants to lend hands to help, and some of them did apply the methodology. Kruger National Park in Africa is using drones as a part of Postcode Meerkat and also day night vision cameras to keep an eye on such activities. The most crucial fact is that the number of wildlife animals is decreasing day by day, and most importantly, the diseases are being spread due to such activities. The worst nightmare in Africa, Ebola, also the SARS and AIDS have all originated due to the animals.

A typical seafood market

The wet market, banned several times in China, still functional in some areas leading to the outbreak, which has re-begun when the virus was found in the seafood market. It’s nearly a wartime scenario in the country. The swab testing recently is done, and guess what, the rise in the cases is observed. If the guidelines are not followed, people looking for freedom might lose their life permanently while fighting with the self-immunity, not even with someone else. Your body is a battlefield now; you have to fight for your system and not by raising questions to others.

At the time of writing this article, the cases are at 10 million, and still, there is no seriousness among the people. Being at home doesn’t mean you’re free; you need to contribute your work and show dedication towards society. We are a social animal, and yes, we also need to be controlled to control the diversion to other illegal tasks.

‘It is a day of universal brotherhood’- PM Modi on International Yoga Day, Mysuru celebrates Yoga indoors, on Terrace

International Yoga Day celebration at Mysuru Palace on Terrace.

Addressing the nation on Sunday 21 June 2020 PM Narendra Modi said this is the day of unity as yoga binds everyone together. “It is a day of universal brotherhood.”

“The theme of International Day of Yoga this year is ‘Yoga at home, Yoga with family’. Today, we will stay away from all social gatherings and do yoga with our family. When family members come together in practicing yoga, it spreads energy in the entire house,” said PM Modi.

“The world is taking the need to practice yoga more seriously in the wake of Covid-19. Yoga has many asanas (poses) to boost our immunity. These asanas strengthen our muscles and metabolism. Coronavirus attacks our respiratory system, and pranayama (breathing exercise) is the best exercise to keep ourselves safe,” the Prime Minister said, urging people to include pranayama in their daily routine.

“Yoga enhances our quest for a healthier planet. It does not discriminate, goes beyond color, race, faith, and nations. Anyone can embrace yoga – all you need is some time and space,” PM Modi said.

He ended the address with Sanskrit verse: Lokah samastah sukhino bhavantu (may all beings be happy and free).

For the first time since June 21, 2015, Yoga Day is being celebrated digitally. This year’s theme is ‘Yoga at home and Yoga with family.’

On December 11, 2014, the United Nations General Assembly had declared June 21 as ‘International Day of Yoga’, months after PM Modi had proposed the idea.

PM Modi had urged people, in a video message on Thursday, to observe the day from the confines of their homes due to the Covid-19 pandemic.

Yoga celebration at Mysuru Palace

Due to the Pandemic outbreak, PM Narendra Modi could not attend the Yoga performance at Mysuru.

Still, the program was conducted at the palace premises under the aegis of the Yoga Federation of Mysuru with the representative from the local AYUSH department.

The program was live-streamed on Social media to encourage the public to perform yoga, where 24 Asanas were performed apart from Pranayama and Dhyana.

“Instead of the single venue outdoor mass yoga session, they can celebrate performing yoga at a time staying in their homes. We hope the people cooperate and support the initiative in the light of pandemic,” he said, in a video message.

At least one lakh people are expected to perform yoga from their homes to celebrate the occasion, he said.

Pratap Simha, Mysuru MP, in a video message, said people could do ‘asanas’ of their choice staying indoors. “We wanted to break the record held by yoga guru Baba Ramdev on the yoga day show this year in Mysuru by attracting a gargantuan crowd. But the pandemic stopped us from making it happen,” he recalled.

“We had sought permission from the Deputy Commissioner tp perform in front of the palace and live to stream the event on social media to popularise yoga. So, in terms of reach, if surpassed our earlier efforts’, said Ganesh Kumar, one of the yoga instructors conducting the event.

Those performing yoga on June 21 in their homes will get a certificate acknowledging their participation.

Traditional learning can’t be replaced by virtual learning

In such times, Virtual classes are the only practice that can help the student to learn without any deterrent. In such a situation of the pandemic, there is no other alternative for now. Most of the institution has adopted for virtual learning via email, video conference through zoom meeting, google meet, Webex, Microsoft etc which is a great step initiated as of now. But in my opinion, traditional learning cannot be replaced. Since there is no direct interaction between a student and a teacher which cause a lot of distraction. Reason being the teacher cannot ensure the focus of the student. Virtual classes have their own benefit you don’t have to worry about waking up early and one can learn according to their comfort zone. Since a student can study in the comfort of their homes. Virtual classes make us able to watch recorded lectures as many times we want which helps us clear our doubts. Virtual classes save time and money but it cannot provide the environment same like classroom learning. One has to ensure good internet supply and interface but not every student has these facilities. As of now, there is some locale where there is lack of internet services. Class learning doesn’t only make learning easier but it also promotes focus, self-disciplined and punctuality in your life, since one has to wake up early to attend the classes on time. Classroom learning offers direct interaction and helps to upgrade their skills and teach them how to peacefully live in a society. But according to this situation, Virtual learning is really important as of now schools and institutions are shut down. In the situation of global health crisis, it is the only way left so the student can keep social distancing and complete their syllabus on time. Switching learning is great for now since it enables the student to be productive as of now. Both ways have their own pros and cons. In virtual learning, there is a lack of understanding between student and teacher. Classroom learning includes conflict resolving skills, presentation skills it boosts up your confidence in front of peers, develops Leadership skills and teaches them to get along with the student from different cultural backgrounds. Classroom teaching is valuable in shaping their communication skills, listening skills and boosting up their confidence. Students experience social interactions with peers and establish rapport with teachers which help develop socially. Classroom learning enhances the critical thinking skills of students in live group discussion. Teachers can modify their teaching practices based on the observation that student is getting what they are taught i.e. classroom activities and interactions can help learners. At the same time, students can get their doubts clarified immediately which is not in the case of virtual learning. since there is a lot of distraction in virtual classes. As of now, we should be grateful that virtual learning is helping the student to be productive in this crisis. Since in the time of emergency virtual learning is a good alternative to traditional learning but cannot be replaced by traditional learning.Since Classroom learning has certain extra advantages that virtual learning cannot replace.

Please let me know your thoughts in the comment below and have a wonderful day.